Correlation Between Candel Therapeutics and Pharvaris
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Pharvaris BV, you can compare the effects of market volatilities on Candel Therapeutics and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Pharvaris.
Diversification Opportunities for Candel Therapeutics and Pharvaris
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Candel and Pharvaris is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Pharvaris go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Pharvaris
Given the investment horizon of 90 days Candel Therapeutics is expected to generate 2.79 times more return on investment than Pharvaris. However, Candel Therapeutics is 2.79 times more volatile than Pharvaris BV. It trades about 0.05 of its potential returns per unit of risk. Pharvaris BV is currently generating about 0.05 per unit of risk. If you would invest 198.00 in Candel Therapeutics on August 31, 2024 and sell it today you would earn a total of 272.50 from holding Candel Therapeutics or generate 137.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.79% |
| Values | Daily Returns |
Candel Therapeutics vs. Pharvaris BV
Performance |
| Timeline |
| Candel Therapeutics |
| Pharvaris BV |
Candel Therapeutics and Pharvaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Pharvaris
The main advantage of trading using opposite Candel Therapeutics and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Pharvaris vs. Cue Biopharma | Pharvaris vs. Eliem Therapeutics | Pharvaris vs. Inhibrx | Pharvaris vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |